Annals of Neurology· 2017Q1
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
- 1,164citations
- Q1SCImago
- 2017year
Short summary
Serum neurofilament light chain (sNfL) levels, measured via an ultrasensitive assay, are higher in multiple sclerosis (MS) patients than healthy controls and strongly correlate with cerebrospinal fluid (CSF) NfL levels.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Pathology and Forensic Medicine
Pathology and Forensic MedicineMedicine